• News Feed
  • Events By OncoDaily
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Immune Oncology
  • Breast Oncology
  • Gastrointestinal Oncology
  • Lung Oncology
  • Hematology
  • Radiotherapy
  • Cancer Types
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • OncoDaily Medical Journal
  • OncoDaily Newsletters
  • OncoDaily Magazine
  • CancerWorld Magazine
  • World Health Magazine
  • Hemostasis Today
  • Fertility News
  • OncoDaily GI
  • OncoDaily Breast
  • OncoDaily IO
  • OncoDaily Lung
  • OncoDaily RT
  • OncoDaily GU
  • OncoDaily AI
  • OncoDaily Biotech
  • Hematology
  • About OncoDaily
  • Services
  • Partners
  • P53 Inc
  • Privacy Policy
  • Contact Us
  • Editorial Policy
  • Disclaimer
  • Cookie Policy
Double Left Left Sep / 2026 Right Double Right
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« Aug    
OncodailyJournal CancerWorld
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • Events By OncoDaily
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

WCLC 2026 Opens in Seoul: Targeted Therapy Moves Earlier as SCLC Enters a New Therapeutic Era

Tedros Adhanom: India Reaches 8 Million HPV Vaccine Doses Milestone

New "Value Cube" Framework in Nature Medicine Seeks to Redefine Value in Global Oncology

Susanna Fletcher Greer: The V is Investing $16.2 Million to Change What’s Possible in Childhood Cancer

SIOP 2026 Welcomes the Global Paediatric Oncology Community to San Antonio

C. Ola Landgren: Bristol Myers Squibb Has Announced Positive Results from QUINTESSENTIAL Trial

Muna Al-Khaifi: Advancing Menopause Care for People Living With and Beyond Cancer

Lymphoma Treatment in China: Research and Clinical Practice

OncoCalendar

7 events found.

Lugano, Switzerland

« All Events

Events at this venue

Today
  • July 2026

  • Wed 8
    ESMO Preceptorship

    ESMO Preceptorship on Endocrine Tumours 2026: Lugano

    Jul 8 - Jul 9
    Lugano, Switzerland

    The ESMO Preceptorship on Endocrine Tumours 2026: Lugano is scheduled for July 8–9, 2026, in Lugano, Switzerland. Co-chaired by Alfredo Berruti and Rocio Garcia-Carbonero, this intensive educational course is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endocrine neoplasms. The curriculum typically focuses on the latest standards of care, […]

  • Wed 1
    Endometrial Cancer

    ESMO Preceptorship on Endometrial Cancer 2026: Lugano

    Jul 1 - Jul 2
    Lugano, Switzerland

    The ESMO Preceptorship on Endometrial Cancer 2026 is a specialized educational course scheduled for July 1–2, 2026, in Lugano, Switzerland. This intensive program is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endometrial cancer, from diagnosis and pathology to advanced therapeutic strategies. Key learning objectives typically include exploring the […]

  • May 2026

  • Fri 15
    Colorectal Cancer 2026

    ESMO Preceptorship on Colorectal Cancer 2026: Lugano

    May 15 - May 16
    Lugano, Switzerland

    The ESMO Preceptorship on Colorectal Cancer 2026: Lugano is a specialized educational course scheduled for May 15–16, 2026, in Lugano, Switzerland. This course is designed to provide oncologists - particularly young and general oncologists - with a comprehensive understanding of colorectal cancer management from diagnosis to treatment. The technical program includes plenary lectures by international […]

  • Wed 13
    Head and Neck Cancer

    ESMO Preceptorship on Head and Neck Cancer 2026: Lugano

    May 13 - May 14
    Lugano, Switzerland

    The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14, 2026, in Lugano, Switzerland. This program is designed to provide medical and clinical oncologists with a deep understanding of the management of head and neck cancers, ranging from diagnosis to advanced treatment strategies. The curriculum covers the […]

  • Mon 11
    Hereditary Cancer Genetics

    ESMO Preceptorship on Hereditary Cancer Genetics 2026: Lugano

    May 11 - May 12
    Lugano, Switzerland

    The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12, 2026, in Lugano, Switzerland. Co-chaired by Judith Balmaña and Marjolijn Ligtenberg, this program is designed to provide oncologists with a comprehensive understanding of the molecular basis of genetic susceptibility to cancer. The technical curriculum focuses on the multidisciplinary […]

  • February 2026

  • Wed 18
    ESMO Preceptorship

    ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano

    Feb 18 - Feb 19
    Lugano, Switzerland

    The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a thorough understanding of current standards of care, molecular pathology, and novel treatment targets. The preceptorship will take place on February 18–19, 2026, in Lugano, Switzerland, […]

  • December 2025

  • Tue 16
    ESMO, Preceptorship on Prostate Cancer

    ESMO Preceptorship on Prostate Cancer 2025: Lugano

    Dec 16, 2025 - Dec 17, 2025
    Lugano, Switzerland

    The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management, from diagnosis to treatment, according to current standards of care. Organized by the European Society for Medical Oncology (ESMO), the event is scheduled to take place on December 16–17, 2025, in Lugano, Switzerland. […]

  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer Breast Cancer cancer care ASCO Lung cancer fight against cancer Cancer research Global fight against cancer Headlines immunotherapy ESMO NSCLC cancer treatment MD Anderson Cancer Center clinical trials colorectal cancer cancer awareness prostate cancer FDA Childhood Cancer Research UICC AACR ASCO24 chemotherapy Pancreatic Cancer radiation oncology Dana-Farber Cancer Institute American Cancer Society AI Precision Oncology Robert Orlowski American Society of Clinical Oncology SIOP European Cancer Organisation NCI National Cancer Institute Myeloma Paper of the Day WHO radiotherapy cervical cancer Paolo Tarantino Myeloma IASLC Vivek Subbiah bladder cancer multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}